Diogo Martins-Branco is a Portuguese Board- and ESMO-certified medical oncologist since 2019. After medical school graduation by the University of Coimbra (2006-2012), he completed his training at the Medical Oncology Department of Instituto Português de Oncologia de Lisboa, Portugal, where he was appointed as Medical Oncology Consultant until December 2020. Between 2021 and 2023, he performed a Clinical Cancer Research Fellowship at the Academic Trials Promoting Team/Clinical Trials Support Unit of Institut Jules Bordet, Brussels, Belgium. Since September 2023, he is Medical Oncology Fellow at the ESMO Scientific and Medical Division, Lugano, Switzerland.

During his training he completed the Clinical Scholars Research Training from Harvard Medical School, USA (2013-2014), and a Master in Palliative Care from King's College London, UK (2015-2017). He also completed a part-time Scientific Communication Fellowship at Champalimaud Foundation, Lisbon, Portugal (2019-2021), collaborating with patient advocacy groups to disseminate the results of an EU Horizon 2020 funded consortium for translational research in uveal melanoma. He was a member of the Health Parliament Portugal (2020-2021), where he chaired the Oncology Committee to produce policy recommendations for the national health system. 

He is co-author of more than 70 publications and conference proceedings in peer-reviewed journals, and recipient of research grants and awards. He participated as investigator or medical advisor in more than 10 clinical trials, and as co-author of observational studies and systematic reviews/meta-analyses. His main areas of interest are breast cancer, precision medicine, clinical research methodology, real-world evidence, epidemiology, and cancer policy.

Dr. Martins-Branco actively participated in different scientific societies. In the Portuguese Society of Oncology, he served as Young Oncologists Committee Chair and member of the Cancer Survivorship Working Group. He is an active ESMO member since 2015 and was selected for several activities, such as congress travel grant, preceptorships, advanced courses, and the Methods in Clinical Cancer Research Workshop 2017. Before joining ESMO, he served as external collaborator of the Real-World Data and Digital Health Working Group, and as extended member of the Cancer Medicines Committee.

X/Twitter: @DMBranco | LinkedIn: dmbranco88